Related Experiment Video
Updated: Apr 30, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Increased serum brain-derived neurotrophic factor levels during opiate withdrawal
Jie Zhang1, XiangYang Zhang2, Hang Su1
1The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, PR China.
Serum levels of brain-derived neurotrophic factor (BDNF) were higher in heroin addicts than controls. BDNF levels did not change significantly after one month of heroin cessation, suggesting its role in opiate addiction.
Area of Science:
- Neuroscience
- Addiction Research
- Biochemistry
Background:
- Brain-derived neurotrophic factor (BDNF) is linked to opiate addiction pathophysiology.
- Conflicting reports exist regarding serum BDNF levels in heroin addicts.
- The role of BDNF during heroin withdrawal remains understudied.
Purpose of the Study:
- To compare serum BDNF levels between heroin addicts and healthy controls.
- To examine serum BDNF level changes in heroin addicts post-cessation.
Main Methods:
- Serum BDNF levels were measured in 72 heroin-dependent patients and 90 controls.
- Measurements were taken at baseline for all participants.
- Heroin addicts were reassessed one month after cessation (37 completed).
Main Results:
- Baseline serum BDNF levels were significantly elevated in heroin addicts compared to controls (p=0.001).
- No significant difference was observed in heroin addicts' serum BDNF levels between baseline and one month after cessation (p=0.301).
Conclusions:
- Elevated serum BDNF may be associated with heroin addiction.
- BDNF levels appear stable during early heroin withdrawal.
- BDNF likely plays a crucial role in opiate addiction and withdrawal processes.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016